{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-034750","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2023-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.856513+00:00","generated_at":"2026-06-10T07:06:10.542429+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Semper Paratus regains Nasdaq MVLS compliance effective Sept 28, 2023","bullets":["Company received Nasdaq letter Sept 28, 2023 confirming regained compliance with MVLS Rule (minimum $50M market value).","Non-compliance notice received April 7, 2023; initial cure period ran to Oct 2, 2023.","MVLS exceeded $50M for ten consecutive business days from Sept 14 to Sept 27, 2023.","Compliance regained; delisting risk from Nasdaq Global Market is removed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-034750","json":"https://secwatch.observer/filing/0001493152-23-034750.json","markdown":"https://secwatch.observer/filing/0001493152-23-034750.md","text":"https://secwatch.observer/filing/0001493152-23-034750.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000149315223034750/0001493152-23-034750-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000149315223034750/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T07:06:10.542429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}